Latest news and insights on the pharmaceutical industry | Indian Pharma Post | Page 5

Results For "ADQ"

173 News Found

Strides receives USFDA approval for Fluoxetine Tabs 10 mg and 20 mg
Drug Approval | April 10, 2024

Strides receives USFDA approval for Fluoxetine Tabs 10 mg and 20 mg

The product is bioequivalent and therapeutically equivalent to the Reference Listed Drug (RLD) Prozac Tablets of Eli Lilly


dsm-firmenich launches food and beverages pilot plant in US
News | March 21, 2024

dsm-firmenich launches food and beverages pilot plant in US

The pilot plant is focused on scaling up beverage production and will support applications


Aster’s India and GCC business separation nearing completion
Healthcare | March 20, 2024

Aster’s India and GCC business separation nearing completion

The plan essentially was to separate Aster’s India and GCC businesses to unlock long-term value


Shilpa Medicare gets Europe approval for Varenicline Tablets, 0.5mg and 1mg
News | February 27, 2024

Shilpa Medicare gets Europe approval for Varenicline Tablets, 0.5mg and 1mg

Varenicline is indicated for smoking cessation in adults


Lupin receives approval from USFDA for Minzoya
Drug Approval | February 17, 2024

Lupin receives approval from USFDA for Minzoya

Minzoya Tablets are indicated for use by females of reproductive potential to prevent pregnancy


Glenmark, Ichnos Sciences form ‘Ichnos Glenmark Innovation’ for new drug discovery in cancer treatment
News | January 30, 2024

Glenmark, Ichnos Sciences form ‘Ichnos Glenmark Innovation’ for new drug discovery in cancer treatment

This alliance brings together drug innovation capabilities of Glenmark and Ichnos to develop cutting-edge therapies for the treatment of hematological malignancies and solid tumors


BenevolentAI appoints former Bayer R&D head Dr. Joerg Moeller as CEO
People | January 25, 2024

BenevolentAI appoints former Bayer R&D head Dr. Joerg Moeller as CEO

An accomplished R&D leader and champion of the application of AI to drug discovery


Lupin launches Varenicline Tablets in US
News | January 11, 2024

Lupin launches Varenicline Tablets in US

Varenicline Tablets (RLD Chantix) had estimated annual sales of US $412 million in the US


GenSci launches global innovation hub in Shanghai
News | December 26, 2023

GenSci launches global innovation hub in Shanghai

The establishment of the facility demonstrates the company's commitment to delivering differentiated solutions to gynecology and pediatrics challenges


PerkinElmer acquires Covaris to create an innovation-led diagnostics platform
News | December 05, 2023

PerkinElmer acquires Covaris to create an innovation-led diagnostics platform

Covaris is a global leader in the development and deployment of end-to-end solutions for high-throughput genomic and proteomic analysis